Once a Class C medical device is successfully registered with Vietnam’s Ministry of Health (MOH), the manufacturer and local authorized representative (LAR) must comply with post-market surveillance (PMS), reporting obligations, and regulatory maintenance to keep the registration valid.
Vietnam MOH requires manufacturers and importers to monitor the safety, quality, and performance of their medical devices after market approval.
✅ Adverse Event Reporting
Any serious incident related to the device must be reported via the MOH DMEC system.
Reporting timelines:
24 hours for life-threatening incidents.
30 days for less severe safety issues.
✅ Quality & Safety Monitoring
Maintain records of complaints, recalls, and corrective actions.
Implement a post-market surveillance (PMS) plan in compliance with ISO 14971 (Risk Management).
✅ Product Recall & Corrective Actions
If a defect or safety concern arises, the company must submit a Corrective and Preventive Action (CAPA) report to MOH.
Follow MOH recall procedures for affected devices.
✅ Labeling Requirements
All products must comply with Vietnamese labeling regulations, including:
Product name and model.
Manufacturer and importer details.
Expiry date (if applicable).
Instructions for Use (Vietnamese translation required).
✅ Distribution & Importation Control
The importer must be registered with MOH and maintain compliance.
Ensure consistent device quality with approved registration details.
✅ Registration Validity
As per Decree 98/2021/ND-CP, Class C medical device registration is valid indefinitely.
However, updates may be required if the device undergoes:
Design or manufacturing changes.
Regulatory updates impacting compliance.
✅ Changes & Modifications
Notify MOH if there are changes in:
Manufacturer information.
Device specifications.
Local authorized representative (LAR).
✅ Regulatory Inspections
MOH may conduct random inspections on registered devices in the market.
Ensure all compliance documents, safety reports, and import records are available.
✅ Document Updates
Maintain updated technical files, risk assessments, and clinical evaluations.
Follow any new regulatory changes issued by MOH.
.jpg)
Whatsapp or Wechat:+86 15816864648;email address:hito.lin@grzan.cn